MatchaDB

2025学位論文無料で読める

Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling

著者の記載なし

UpSpace Institutional Repository (University of Pretoria)

無料の全文→

要旨

Green and dark teas are rich in bioactive compounds with potential therapeutic effects in the management of type 2 diabetes mellitus (T2DM). This study aimed to comprehensively evaluate the antidiabetic potential of green and dark teas through an integrated experimental and computational workflow, incorporating metabolomics, enzyme inhibition assays, antioxidant assays, liver cell-based assays, and molecular modelling. A total of 24 commercially available tea samples, green, dark, black, matcha, and rooibos were sourced, and these teas were subjected to untargeted liquid chromatography-mass spectrometry (LC/MS) based metabolomics in negative ion mode to characterise their chemical compositions. Matcha tea served as a positive control due to its well-documented bioactivity, while rooibos served as a negative control since it is derived from a botanically unrelated plant. Black tea was included to differentiate metabolites arising from microbial fermentation in dark tea versus those generated via enzyme oxidation found in black tea. Metabolomic profiling revealed that green and dark teas share a core set of polyphenolic compounds, including epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and gallic acid. Each tea exhibited unique signatures linked to fermentation and processing. Dark teas also contained additional fermentation-related metabolites such as ellagic acid derivatives and esculetin. Enzyme inhibition assays showed that green tea exhibited the strongest inhibition of both α-glucosidase (IC₅₀ = 20.09 ± 3.22 µg/mL) and α-amylase (IC₅₀ = 1.59 ± 0.11 mg/mL), showing significantly greater activity than the other teas (α < 0.001). Matcha and black teas displayed moderate inhibition (α > 0.05 between them), while dark tea showed weaker activity (IC₅₀ =…

要旨は短縮されています。出典で要旨の全文を読む。

要旨の文章はPubMed、OpenAlex、Europe PMCから取得したもので、著者と出版社に帰属します。

研究の種類

ランダム化比較試験

参加者を無作為に抹茶群か比較群に割り付けた研究。

タイトル、要旨、件名から自動的に割り当てています。

トピック

ここでは抹茶が主題のひとつです(キーワードに記載)。

キーワードと件名

あなたのリサーチフォルダー

この研究を引用する

(2025). Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling. UpSpace Institutional Repository (University of Pretoria).

代謝と体重についてさらに

2018学術論文

Effect of tea products on the in vitro enzymatic digestibility of starch.

Zhang H, Jiang Y, Pan Jほか — Food chemistry

The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノール腸とマイクロバイオーム被引用76回
2018学術論文無料で読める

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノールがん被引用75回
2020学術論文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJほか — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

動物研究代謝と体重腸とマイクロバイオーム市場・文化・持続可能性被引用74回

ライブラリ全体を見る→